ArticleEuropean journal of pediatrics2026
Real-world modality selection and outcomes in neonatal kidney replacement therapy: a single-center cohort study.
Article in European journal of pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To describe biochemical and clinical outcomes of peritoneal dialysis (PD) and continuous kidney replacement therapy (CKRT) in neonates requiring kidney replacement therapy (KRT), and to identify factors associated with mortality. This retrospective single-center study included neonates who underwent KRT between January 2013 and December 2025. Patients were grouped as PD, CKRT, or sequential PD + CKRT. Demographics, indications, biochemical response, complications, and outcomes were analyzed. Eighty-five neonates were included: 42 (49%) PD, 23 (27%) CKRT, and 20 (24%) sequential PD + CKRT. PD patients had lower gestational age and birth weight than CKRT patients (p < 0.05). Acute kidney injury (AKI) was the most common indication overall, whereas inborn errors of metabolism predominated in the CKRT group (61%). CKRT achieved greater early reductions in blood urea nitrogen, creatinine, and ammonia/leucine within 24 h (all p < 0.05); however, end-of-treatment biochemical outcomes were similar between modalities. Treatment duration was shorter with CKRT (p < 0.001), while hospital stay and survival were comparable. Non-survivors had lower birth weight, more frequent invasive mechanical ventilation, higher rates of AKI, and higher complication rates (p < 0.05). In multivariable analysis, the presence of KRT-related complications was the only variable independently associated with mortality (OR 12.69, p = 0.024). CKRT use increased over time (26% vs. 44%), with a non-significant increase in survival (25% to 60%, p = 0.193).
conclusionCKRT and PD achieved acceptable outcomes when selected according to patient characteristics and clinical needs. KRT-related complications were independently associated with mortality, likely reflecting illness severity, rather than a direct causal effect. Multicenter studies are needed to define modality selection in KRT. WHAT IS KNOWN: • Neonatal kidney replacement therapy (KRT) is a lifesaving intervention in critically ill infants. • Peritoneal dialysis (PD) has traditionally been used more frequently due to its technical feasibility in small infants. • Continuous kidney replacement therapy (CKRT) provides more rapid solute clearance but is more complex to implement. WHAT IS NEW: • PD and CKRT achieved acceptable outcomes when selected according to patient characteristics and clinical needs. • KRT-related complications were independently associated with mortality (OR 12.69, p = 0.024); however, this association should be interpreted with caution given potential confounding by illness severity, rather than a direct causal effect.
Indexed as
Identifiers
42579192What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.